PPT-Karima salama Ovarian cancer

introduction S econd most common gynecologic malignancy I n developed countries the incidence of 94 per 100000 women and a mortality rate of 51 per 100000 In developing countries it is the third most common gynecologic malignancy cervical cancer is the most common with an incidence of 50 per 100000 and a mortality rate of 31 per 100000 . in . Primary Care. When to refer?. Physiological/pathological. Benign/malignant. Surgical approach?. . Open or keyhole?. Do I need to do anything?. . Conservative or active . Mx. Learning Points. Ovarian Cancer. Epithelial Tumor, . postmenopausal women. Germ cell,. younger women. Sex cord-stromal origin,. any age. Approximately 90% of ovarian cancer is epithelial . significant . therapeutic challenges . Talking point:. Genetics of ovarian cancer. 49F. Underwent risk-reduction surgery. Total hysterectomy and bilateral . salpingo. -oophorectomy. Significant family history . Sister passed away in her 40s due to breast cancer. Update for GPs. R D Clayton MD MRCOG. Consultant Gynae Oncologist. Gynaecological Cancer Incidence 2011. Gynaecological Cancer mortality 2010. Urgent Gynaecological Cancer Referral. NICE Guidelines. Refer Urgently:. Rob . Gornall. Consultant Gynaecology. GHNHST. How do we benchmark ourselves?. Survival. Stage at presentation. Audit against agreed referral guidelines. Are pathways agreed fit for purpose?. What information/resource is there . Ukurasa wa 1 kati ya 3 https://www.cdc.gov/disasters/hurricanes/be - safe - after.html 9/2/2017 Vituo vya Kudhibiti na Kuzuia Magonjwa CDC 24/7: Kuokoa Maisha, Kuwalinda Watu™ Kuwa Salama Baada ya Christopher Morse, MD. Fellow, Gynecologic oncology. UW MEDICINE. CONFIDENTIAL – DO NOT DISTRIBUTE. Overview. Introduction to ovarian cancer. Diagnosis and treatment. Surgery and chemotherapy. Surveillance. DR PRITI JOSHI MBBS, MD, . FRCPath. CONSULTANT ANATOMIC PATHOLOGIST. CLEVELAND CLINIC ABU DHABI. &. CLINICAL ASSOCIATE PROFESSOR . CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE OHIO. CASE 1. 32 year old female – bilateral . :. . Ass. Prof. . Dr. Ban . Hadi. Hameed. Mustansiriyah. university 2021. LEARNING OBJECTIVES:. Fifth year students should be able to:. Describe the types of malignant ovarian . tumours. Summarize the important points in history and examination to reach the diagnosis. Stuart Salfinger. Gynaecologic Oncologist. MBBS, FRANZCOG, CGO, Dip . Surg. Ed. Ovarian Carcinoma. Leading cause fatality gynaecologic cancer. Incidence 1.5% lifetime risk. 75% present stage 3+. Stage 3 disease 30% 5 year survival. Genetics of ovarian cancer. 49F. Underwent risk-reduction surgery. Total hysterectomy and bilateral . salpingo. -oophorectomy. Significant family history . Sister passed away in her 40s due to breast cancer. by. Nancy A. Rice, Department of Biology, Western Kentucky University, and. Bruno Borsari, Biology Department, Winona State University. 1. Abby is Sick:. Review of the Story So Far…. Abby has been having abdominal pain.. granulosa. cell . tumours. Jo Moffatt ST4. Claire Newton. St Michael’s Hospital, Bristol. Background. Aims and methods. Results. Conclusions. Adult . granulosa. cell . tumours. Type of sex cord stromal . Singh. MD (AIIMS), FICOG. Dept. of Obstetrics & Gynecology. King George Medical University. Lucknow. INTRODUCTION. Fourth most common cause of death in women. 30% of genital malignancies in the developed countries .